Psychemedics (NASDAQ:PMD) Share Price Passes Above 200-Day Moving Average – What’s Next?

Psychemedics Co. (NASDAQ:PMD) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.33 and traded as high as $2.35. Psychemedics shares last traded at $2.33, with a volume of 26,766 shares changing hands.

Psychemedics Trading Down 0.4 %

The company has a debt-to-equity ratio of 0.01, a current ratio of 1.59 and a quick ratio of 1.59. The business’s 50 day simple moving average is $2.32 and its 200 day simple moving average is $2.33. The company has a market capitalization of $13.72 million, a price-to-earnings ratio of -4.57 and a beta of 0.65.

About Psychemedics

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol.